REBLOZYL® (luspatercept-aamt) for the Treatment of Anaemia Associated with Beta-Thalassemia

Image 1-REBLOZYL® (luspatercept-aamt) for the Treatment of Beta-Thalassemia-Associated Anaemia
REBLOZYL® (luspatercept-aamt) is an erythroid maturation agent (EMA) indicated for the treatment of beta-thalassemia-associated anaemia. Credit: Celgene Corporation.